Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Moran-Salvador

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cellular and Molecular Gastroenterology and Hepatology|June 9, 2017
Epigenetics and Liver FibrosisEva Moran-Salvador, Jelena Mann
Journal of Hepatology|December 4, 2015
Hepatic stellate cell transdifferentiation involves genome-wide remodeling of the DNA methylation landscapeAgata Page, Pier Paoli, Eva Moran Salvador, et al.
Gastroenterology|July 29, 2019
Fibrogenic Activity of MECP2 Is Regulated by Phosphorylation in Hepatic Stellate CellsEva Moran-Salvador, Marina Garcia-Macia, Ashwin Sivaharan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin AMüjdat Zeybel, Saimir Luli, Laura Sabater, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cellular and Molecular Gastroenterology and Hepatology|June 9, 2017
Epigenetics and Liver FibrosisEva Moran-Salvador, Jelena Mann
Journal of Hepatology|December 4, 2015
Hepatic stellate cell transdifferentiation involves genome-wide remodeling of the DNA methylation landscapeAgata Page, Pier Paoli, Eva Moran Salvador, et al.
Gastroenterology|July 29, 2019
Fibrogenic Activity of MECP2 Is Regulated by Phosphorylation in Hepatic Stellate CellsEva Moran-Salvador, Marina Garcia-Macia, Ashwin Sivaharan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin AMüjdat Zeybel, Saimir Luli, Laura Sabater, et al.
Pageof 1